Tinzaparin Sodium



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 24.9%
Diffuse Large B-cell Lymphoma 13.9%
Pulmonary Embolism 8.7%
Acute Coronary Syndrome 6.9%
Non-small Cell Lung Cancer 6.9%
Non-hodgkin's Lymphoma 5.8%
Prostate Cancer 5.2%
Thrombosis Prophylaxis 5.2%
Ventricular Dysfunction 4.6%
Deep Vein Thrombosis 4.0%
Colon Cancer 2.3%
Pulmonary Infarction 2.3%
Epilepsy 1.7%
Erysipelas 1.7%
Supraventricular Tachycardia 1.7%
Ankylosing Spondylitis 1.2%
Prophylaxis 1.2%
Anxiety 0.6%
Conjunctivitis 0.6%
Drug Use For Unknown Indication 0.6%
Epistaxis 10.5%
Thrombosis 10.5%
Upper Gastrointestinal Haemorrhage 10.5%
Hypertension 7.9%
Toxic Epidermal Necrolysis 7.9%
Cerebral Haemorrhage 5.3%
Drug Rash With Eosinophilia And Systemic Symptoms 5.3%
Haematuria 5.3%
Priapism 5.3%
Sciatica 5.3%
Cholestasis 2.6%
Condition Aggravated 2.6%
Disability 2.6%
Haematoma 2.6%
Hidradenitis 2.6%
Hyperkalaemia 2.6%
Metrorrhagia 2.6%
Peripheral Artery Aneurysm 2.6%
Skeletal Injury 2.6%
Thrombocytopenia 2.6%
Concomitant
Product Used For Unknown Indication 15.5%
Drug Use For Unknown Indication 11.3%
Prophylaxis 9.7%
Hiv Infection 8.0%
Hypertension 6.7%
Non-small Cell Lung Cancer 6.2%
Arrhythmia 5.1%
Breast Cancer 5.1%
Thrombosis Prophylaxis 4.3%
Pain 3.8%
Ovarian Cancer Metastatic 3.2%
Chronic Obstructive Pulmonary Disease 2.7%
Abdominal Sepsis 2.4%
Blood Pressure 2.4%
Lung Neoplasm Malignant 2.4%
Metastatic Renal Cell Carcinoma 2.4%
Pancreatic Carcinoma 2.4%
Chemotherapy 2.1%
Colorectal Cancer 2.1%
Non-small Cell Lung Cancer Stage Iv 2.1%
Pneumonia 8.8%
Weight Decreased 8.8%
Septic Shock 7.4%
Cytolytic Hepatitis 5.9%
Drug Interaction 5.9%
Renal Failure 5.9%
Therapy Cessation 5.9%
Venous Thrombosis 5.9%
Atrial Fibrillation 4.4%
Dehydration 4.4%
Febrile Neutropenia 4.4%
Myalgia 4.4%
Pulmonary Embolism 4.4%
Transfusion Reaction 4.4%
Vomiting 4.4%
Acute Myocardial Infarction 2.9%
Bronchitis 2.9%
Cerebrovascular Accident 2.9%
Deep Vein Thrombosis 2.9%
Device Related Infection 2.9%